NASDAQ · SEPN
Septerna, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for SEPN: Nov 9, 2026
Septerna, Inc. Common Stock is estimated to report earnings on 11/09/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.55. The reported EPS for the same quarter last year was $-0.09.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.55 | $-0.31 | $-0.91 | 5 |
| Dec 2026 | $-0.57 | $-0.35 | $-0.99 | 5 |
| Mar 2027 | $-0.44 | $-0.33 | $-0.50 | 3 |
| Jun 2027 | $-0.45 | $-0.27 | $-0.56 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · BNK Invest · Zacks · The Motley Fool- RTTNews · Aug 25, 8:38 AM EDTSepterna Appoints Rajiv Patni, M.D., As Chief Medical Officer(RTTNews) – Septerna Inc. (SEPN), a clinical-stage biotechnology company advancing therapies targeting G-protein coupled receptor (GPCR), announced the appointment of industry veteran Rajiv Patni, M.D., as Chief Medical Officer.
- BNK Invest · Aug 12, 9:38 AM EDTSepterna Reaches Analyst Target PriceIn recent trading, shares of Septerna Inc (Symbol: SEPN) have crossed above the average analyst 12-month target price of $45.00, changing hands for $47.71/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati
- Zacks · Aug 10, 5:10 PM EDTSepterna, Inc. (SEPN) Reports Q2 Loss, Beats Revenue EstimatesSepterna, Inc. (SEPN) delivered earnings and revenue surprises of +39.58% and +30.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 6, 9:50 AM EDTRoivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue EstimatesMontes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of 0.00% and -35.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 5, 9:00 AM EDTEntrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Tops Revenue EstimatesEntrada Therapeutics (TRDA) delivered earnings and revenue surprises of +12.93% and +2.05%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · Jul 5, 9:55 AM EDTSepterna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors?Samira Shaikhly sold 11,798 shares of Common Stock on May 26, 2026, for a transaction value of ~$355,000.
- The Motley Fool · Jun 29, 11:25 PM EDTIs Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares?15,000 shares were exercised and sold for a total of ~$533,000 on June 22, 2026, at a weighted average price of around $35.51 per share.
- Zacks · May 11, 5:25 PM EDTSepterna, Inc. (SEPN) Reports Q1 Loss, Tops Revenue EstimatesSepterna, Inc. (SEPN) delivered earnings and revenue surprises of +63.04% and +32.93%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 11, 7:45 AM EDTLiquidia Corporation (LQDA) Surpasses Q1 Earnings and Revenue EstimatesLiquidia Corporation (LQDA) delivered earnings and revenue surprises of +54.76% and +22.11%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 7, 7:05 PM EDTZymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue EstimatesZymeworks (ZYME) delivered earnings and revenue surprises of -510.13% and -94.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 4, 8:15 AM EDTAxsome Therapeutics (AXSM) Reports Q1 Loss, Beats Revenue EstimatesAxsome (AXSM) delivered earnings and revenue surprises of -48.03% and +1.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Fintel · Mar 26, 11:53 PM EDTSepterna (SEPN) Price Target Increased by 34.39% to 46.41The average one-year price target for Septerna (NasdaqGM:SEPN) has been revised to $46.41 / share. This is an increase of 34.39% from the prior estimate of $34.53 dated February 21, 2026. The price target is an average of many targets provided by analysts. The
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Septerna, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.